PT - JOURNAL ARTICLE AU - Blanco, Magali N. AU - Gassett, Amanda AU - Gould, Timothy AU - Doubleday, Annie AU - Slager, David L. AU - Austin, Elena AU - Seto, Edmund AU - Larson, Timothy AU - Marshall, Julian AU - Sheppard, Lianne TI - Characterization of annual average traffic-related air pollution levels (particle number, black carbon, nitrogen dioxide, PM<sub>2.5</sub>, carbon dioxide) in the greater Seattle area from a year-long mobile monitoring campaign AID - 10.1101/2021.09.18.21263522 DP - 2022 Jan 01 TA - medRxiv PG - 2021.09.18.21263522 4099 - http://medrxiv.org/content/early/2022/02/14/2021.09.18.21263522.short 4100 - http://medrxiv.org/content/early/2022/02/14/2021.09.18.21263522.full AB - Growing evidence links traffic-related air pollution (TRAP) to adverse health effects. We designed an innovative and extensive mobile monitoring campaign to characterize TRAP exposure levels for the Adult Changes in Thought (ACT) study, a Seattle-based cohort. The campaign measured particle number concentration (PNC) to capture ultrafine particles (UFP), black carbon (BC), nitrogen dioxide (NO2), fine particulate matter (PM2.5), and carbon dioxide (CO2) at 309 stop sites representative of the cohort. We collected about 29 two-minute visit measures at each site during all seasons, days of the week, and most times of day during a one-year period. Validation showed good agreement between our BC, NO2, and PM2.5 measurements and regulatory monitoring sites (R2 = 0.68-0.73). Universal kriging–partial least squares models of annual average pollutant concentrations had cross-validated mean square error-based R2 (and root mean square error) values of 0.77 (1,177 pt/cm3) for PNC, 0.60 (102 ng/m3) for BC, 0.77 (1.3 ppb) for NO2, 0.70 (0.3 µg/m3) for PM2.5, and 0.50 (4.2 ppm) for CO2. Overall, we found that the design of this extensive campaign captured the spatial pollutant variations well and these were explained by sensible land use features, including those related to traffic.Synopsis We develop well-performing, long-term average pollutant exposure prediction models for epidemiologic application from an innovative and extensive short-term mobile monitoring campaign.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Adult Changes in Thought - Air Pollution (ACT-AP) Study (National Institute of Environmental Health Sciences [NIEHS], National Institute on Aging [NIA], R01ES026187), BEBTEH: Biostatistics, Epidemiologic &amp; Bioinformatic Training in Environmental Health (NIEHS, T32ES015459), and the University of Washington Interdisciplinary Center for Exposure, Disease, Genomics &amp; Environment (NIEHS, 2P30 ES007033-26). Research described in this article was conducted in part under contract to the Health Effects Institute (HEI), an organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. CR-83998101) and certain motor vehicle and engine manufacturers. The contents of this article do not necessarily reflect the views of HEI, or its sponsors, nor do they necessarily reflect the views and policies of the EPA or motor vehicle and engine manufacturers.  Neither the authors nor their institutions at any time received payment or services from a third party for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No human subjects were involved in this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data presented in this work may be available upon request.